Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Vaccination
Vaccination - Credit: belchonock / DepositPhotos - License: DepositPhotos
Health
Coronavirus
SARS-CoV-2
Covid-19
AstraZeneca
Oxford University
AZD1222
side effect
Wednesday, 9 September 2020 - 07:25
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

Netherlands backed vaccine research paused over possible side effect

AstraZeneca and the University of Oxford temporarily halted their clinical trials on a coronavirus vaccine due to a potential serious side effect in one of their British test subjects, AstraZeneca said in a statement to several international media. This is one of the vaccines that the Netherlands is backing.

The pharmaceutical giant did not say exactly what the side effect was and when it occurred. The pause in the trial is to determine whether the illness was caused by the vaccine, or whether the British subject got ill for another reason. According to AstraZeneca, the pause is a routine part of the vaccine trial procedure.

It is unclear how long this pause will last, but the company hopes that the trial can still be completed on time.

Clinical trials for the AstraZeneca vaccine were ongoing in the United States and the United Kingdom, with smaller studies in Brazil and South Africa.

University of Washington researcher Deborah Fuller, who is working on a different Covid-19 vaccine that hasn't started human testing yet, told AP news that this potential side effect was likely serious enough to require hospitalization for it to trigger a pause. "This is not something to be alarmed about," Fuller said. She rather finds it reassuring that the company is pausing to trial to figure out what is going on and carefully monitoring the health of participants.

The first test results with this vaccine, called AZD1222, were published in July and were positive. Some side effects were noted, but none of them serious.

In June the Netherlands teamed up with France, Germany and Italy, pooling their purchasing power to acquire between 300 and 400 million units of this vaccine by AstraZeneca. The Netherlands also negotiated with the EU for the purchase of four other vaccines, including one being developed by Janssen in Leiden. Experts said that the Oxford vaccine showed the most promise.

Follow us:

Latest stories

  • Dutch Eurovision singer Heddy Lester dies at age 72
  • Utrecht civil servants begin weeklong strike
  • Princess Beatrix, the former queen, celebrate her 85th birthday
  • One hospitalized as firefighters battle large residential blaze in Arnhem
  • Regions outside Randstad against limiting international students
  • Train passengers can check in and out using contactless cards & devices from today

Top stories

  • Regions outside Randstad against limiting international students
  • Rutte, Macron and Biden not yet ready to give Ukraine F-16 jets
  • Housing construction at highest level in decade; Still 26% below gov't target
  • Threats prompt the Netherlands to close its Istanbul consulate to the public
  • Pro-Russian hackers Killnet behind Groningen hospital cyberattack
  • Regional transport will strike for five days from February 6

© 2012-2023, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content